Sabra Health Care REIT, Inc. SBRA
Set alert
19.78 USD +0.04 +0.20%
As of Nov 2, 10:11 AM ET
19.71 Day range 19.93
17.54 52-week range 22.77
- YTD
- +4.44%
- 1 year
- +11.00%
- Open
- 19.93
- Prev close
- 19.74
- Mkt cap
- 5.05B
- Vol
- 227.79K
- Avg vol
- 2.39M
- EPS
- 0.25
- P/E
- 79.14
- Div yield
- 6.12%
More statistics
- Low
- 19.71
- High
- 19.93
- Forward P/E
- 24.37
- Beta
- 0.62
- Short ratio
- 6.95
- Inst. own
- 105.25%
- Dividend
- 1.20
- Ex-div date
- Aug 13, 2026
- Earnings
- Nov 2, 2026
- 50-d avg
- 19.89
- 200-d avg
- 19.97
- 1y target
- 22.36
2Y chart
Events in this range
- Nov 15, 2024Dividend: 0.3
- Feb 14, 2025Dividend: 0.3
- May 16, 2025Dividend: 0.3
- Aug 4, 2025Earnings: 0.28; estimate 0.18; surprise 55.56%
- Aug 15, 2025Dividend: 0.3
- Nov 5, 2025Earnings: 0.094; estimate 0.1834; surprise -48.75%
- Nov 17, 2025Dividend: 0.3
- Feb 12, 2026Earnings: 0.11; estimate 0.17; surprise -35.29%
- Feb 13, 2026Dividend: 0.3
- Apr 29, 2026Earnings: 0.16; estimate 0.1667; surprise -4.02%
- May 15, 2026Dividend: 0.3
- Aug 3, 2026Earnings: -0.1; estimate 0.1711; surprise -158.45%
- Aug 6, 2026Rating: Raymond James · Underperform → Market Perform
- Aug 14, 2026Dividend: 0.3
- Aug 31, 2026Rating: Baird · Neutral → Neutral
- Aug 31, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 13, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 13, 2026Rating: UBS · Neutral → Neutral
- Oct 19, 2026Rating: Wells Fargo · Overweight → Overweight
- Nov 2, 2026Earnings: —; estimate 0.1637; surprise —%
Signals (95)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jul 21, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| RSI: Oversold | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 28, 2026 | 5 months ago |
| MACD: Sell Signal | May 22, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 28, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 22, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 7, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Apr 2, 2026 | 7 months ago |
| SMA: Bearish | Mar 26, 2026 | 7 months ago |
| SMA: Bullish | Mar 25, 2026 | 7 months ago |
| SMA: Bearish | Mar 20, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 5, 2026 | 8 months ago |
| RSI: Overbought | Feb 17, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Feb 5, 2026 | 9 months ago |
| SMA: Bullish | Feb 5, 2026 | 9 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 22, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 15, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Dec 24, 2025 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 10, 2025 | 10 months ago |
| SMA: Bullish | Nov 6, 2025 | 12 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| MACD: Buy Signal | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 28, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 16, 2025 | 1 year ago |
| RSI: Oversold | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 26, 2025 | 1 year ago |
| SMA: Bearish | Sep 24, 2025 | 1 year ago |
| SMA: Bullish | Sep 23, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 3, 2025 | 1 year ago |
| RSI: Overbought | Aug 20, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 29, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 6, 2025 | 1 year ago |
| SMA: Bullish | Jun 4, 2025 | 1 year ago |
| SMA: Bearish | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| MACD: Sell Signal | May 21, 2025 | 1 year ago |
| MACD: Buy Signal | May 19, 2025 | 1 year ago |
| MACD: Sell Signal | May 14, 2025 | 1 year ago |
| MACD: Buy Signal | May 7, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 25, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| SMA: Bearish | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| SMA: Bullish | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Mar 11, 2025 | 1 year ago |
| SMA: Bullish | Mar 7, 2025 | 1 year ago |
| SMA: Bearish | Mar 6, 2025 | 1 year ago |
| SMA: Bullish | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 27, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 21, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 19, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 11, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 31, 2024 | 1 year ago |
Key statistics
- Market cap
- 5.04B
- Enterprise value
- 7.40B
- Trailing P/E
- 78.96
- Forward P/E
- 24.37
- PEG ratio
- 5.28
- Price / sales
- 5.84
- Price / book
- 1.83
- EPS (TTM)
- 0.25
- Beta
- 0.62
- Dividend yield
- 6.12%
- Payout ratio
- 480.00%
- Profit margin
- 7.58%
- Revenue (TTM)
- 863.77M
- Revenue growth
- 25.30%
- Free cash flow
- 155.12M
- Total cash
- 246.31M
- Total debt
- 2.63B
- Return on equity
- 2.39%
- Shares outstanding
- 255.46M
- Short % of float
- 9.51%
- 50-day average
- 19.89
- 200-day average
- 19.97
Analyst view
Consensus: buy
Buy
Price target (mean) 22.36 +13.0% upside
Now 19.78
- Target (low)
- 19.00
- Target (mean)
- 22.36
- Target (high)
- 25.00
Ratings (0m) 16 6 buy · 10 hold · 0 sell
- Strong buy1
- Buy5
- Hold10
- Sell0
- Strong sell0
Next earnings
Nov 2, 2026
Expected Nov 2, 2026. Consensus EPS estimate 0.165.
Financials — quick view
SBRA Revenue — quarterly 235.87M
SBRA Net income — quarterly -25.20M
SBRA EPS — quarterly -0.10
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2026 | Sep 30, 2026 | 0.1637 | — | — | — |
| Aug 3, 2026 | Jun 30, 2026 | 0.1711 | -0.10 | -0.27 | -158.45% |
| Apr 29, 2026 | Mar 31, 2026 | 0.1667 | 0.16 | -0.01 | -4.02% |
| Feb 12, 2026 | Dec 31, 2025 | 0.17 | 0.11 | -0.06 | -35.29% |
| Nov 5, 2025 | Sep 30, 2025 | 0.1834 | 0.094 | -0.09 | -48.75% |
| Aug 4, 2025 | Jun 30, 2025 | 0.18 | 0.28 | +0.10 | +55.56% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Wells Fargo | main | Overweight | Overweight |
| Oct 13, 2026 | UBS | main | Neutral | Neutral |
| Oct 13, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Baird | main | Neutral | Neutral |
| Aug 6, 2026 | Raymond James | up | Underperform | Market Perform |
About Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Country
- United States
- Website
- sabrahealth.com
News
- Senior Housing Demand Is Rising. Can These 4 REITs Turn It Into Bigger Dividends?
- Wells Fargo Maintains Overweight on Sabra Health Care REIT, Lowers Price Target to $21
- UBS Maintains Neutral on Sabra Health Care REIT, Lowers Price Target to $20
- Barclays Maintains Equal-Weight on Sabra Health Care REIT, Lowers Price Target to $21
- Barclays Maintains Equal-Weight on Sabra Health Care REIT, Raises Price Target to $23
- Baird Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $21
- This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
- Raymond James Upgrades Sabra Health Care REIT to Market Perform
- Sabra Health Care REIT Lowers FY2026 FFO Guidance from $1.55-$1.59 to $1.53-$1.55 vs $1.55 Est
- Sabra Health Care REIT Q2 FFO $0.39, Inline, Sales $235.866M Beat $219.689M Estimate
Your note
Sign in to keep a note on SBRA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBAROSH CRAIG A | Director | Stock Award(Grant) | Aug 30, 2026 | 159,033 |
| COSTA MICHAEL LOURENCO | Chief Financial Officer | Stock Award(Grant) | Aug 30, 2026 | 470,870 |
| CUSACK CATHERINE | Director | Stock Award(Grant) | Aug 30, 2026 | 82,847 |
| FLORES JESSICA | Officer | Stock Award(Grant) | Aug 30, 2026 | 72,476 |
| FOSTER MICHAEL JEFFREY | Director | Stock Award(Grant) | Aug 30, 2026 | 125,246 |
| KATZMANN LYNNE S. | Director | Stock Award(Grant) | Aug 30, 2026 | 86,912 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.29% | 41,614,351 | 821.47M | Jun 29, 2026 |
| Principal Financial Group, Inc. | 9.67% | 24,706,070 | 487.70M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 9.14% | 23,352,373 | 460.98M | Jun 29, 2026 |
| State Street Corporation | 4.82% | 12,305,655 | 242.91M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.44% | 11,349,125 | 224.03M | Jun 29, 2026 |
| Geode Capital Management, LLC | 3.10% | 7,909,172 | 156.13M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Real Estate Index Fund | 3.75% | 9,591,242 | 189.33M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 9,099,666 | 179.63M | Sep 29, 2026 |
| Principal Funds, Inc-Real Estate Securities Fund | 3.24% | 8,264,998 | 163.15M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.13% | 8,001,962 | 157.96M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.61% | 6,655,161 | 131.37M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.26% | 5,786,194 | 114.22M | Jun 29, 2026 |